Atlas Trials

A Study to Evaluate the Tolerance, Efficacy and Pharmacokinetics of TQB3558 Tablets

Clinical trial NCT04408079 · UNKNOWN

Trial details

NCT number
NCT04408079
Sponsor
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Advanced Solid Tumors
Start date
2020-06-25
Primary completion
2022-07-31
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.